Interleukin 6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning
BackgroundCancer cachexia is a progressive and multi factorial metabolic syndrome characterized by loss of adipose tissue and skeletal muscle. White adipose tissue (WAT) lipolysis and white to brown transdifferentiation of WAT (WAT browning) are proposed to contribute to WAT atrophy in cancer cachexia. Chronic inflammation, mediated by cytokines such as tumor necrosis factor alpha (TNF a) and interleukin 6 (IL 6) has been reported to promote cancer cachexia. However, whether chronic inflammation promotes cancer cachexia by regulating WAT metabolism and the underlying mechanism remains unclear.MethodsIn this study, we first analyzed the association between chronic inflammation and WAT metabolism in gastric and colorectal cancer cachectic patients. In cachectic mice treated with anti IL 6 receptor antibody, we clarified whether WAT lipolysis and browning were regulated by IL 6.ResultsClinical analyses showed positive significant association between serum IL 6 and free fatty acid (FFA) both in early and late stage cancer cachexia. However, serum TNF a was positively associated with serum FFA in the early but not late stage cachexia. WAT lipolysis was increased in early and late stage cachexia, while WAT browning was detected only in late stage cachexia. Anti IL 6 receptor antibody inhibited WAT lipolysis and browning in cachectic mice.ConclusionsBased on these findings, we conclude that chronic inflammation (especially that mediated by IL 6) might promote cancer cachexia by regulating WAT lipolysis in early stage cachexia and browning in late stage cachexia.
Lipids in Health and Disease